Zhiying Pan

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Jan B. Vermorken, Jan Stöhlmacher-Williams, Lisa Licitra et al. · The Lancet Oncology · 2013 · 433 citations · Full text

Medicine, Oncology, Chemotherapy +10

The effect of one injection of Depo-Provera® on the human vaginal epithelium and cervical ectopy

Christine Mauck, Marianne M. Callahan, Jay M. Baker et al. · Contraception · 1999 · 119 citations

Medicine, Gynecology, Obstetrics +8

Goodness‐of‐Fit Methods for Generalized Linear Mixed Models

Zhiying Pan, D. Y. Lin · Biometrics · 2005 · 109 citations

Business, Biostatistics, Epidemiologic Methods +16

Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non–small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

Nicholas Thatcher, Jerome H. Goldschmidt, Michael Thomas et al. · Clinical Cancer Research · 2019 · 67 citations

Medicine, Oncology, Pharmacology +12

A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men

Richárd Márkus, Vincent Chow, Zhiying Pan et al. · Cancer Chemotherapy and Pharmacology · 2017 · 43 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14